PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
0.99
-0.02 (-1.83%)
At close: Aug 20, 2025, 9:41 AM
PharmaCyte Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Net Income | 11.75M | -3.05M | -1.47M | 23.42M | 1.35M | -619.54K | 2.79M | -3.18M | -126.34K | -764.14K | -1.88M | -1.55M | -1.42M | -811.29K | -979.75K | -1.03M | -960K | -757.1K | -950.19K | -883.94K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 63.94K | 72.86K | 119.16K | 222.68K | n/a | 674.69K | n/a | n/a | -638.07K | 629.93K | 8.13K | 7.34K | 5.67K | 15.65K | 21.44K | 35.2K | 20.64K | 87.17K | 123.38K | 139.64K |
Other Working Capital | 1.34M | 285.85K | 79.69K | -38.91K | 181.98K | -222.3K | 37.36K | -589.85K | 149.73K | 7.84K | -309.14K | 97.35 | 109.63K | 558.73K | -423.17K | -269.25K | -24.05K | 76.34K | -138.08K | -46.23K |
Other Non-Cash Items | -14.11M | 2.04M | 421.34K | -24.14M | -1.77M | -368K | -4.22M | 2.9M | 643.95K | 165.87K | -294.12K | 2.28K | 3.07K | 2.44K | 4.57K | 24.77K | -69.99K | 5.41K | 19.16K | 40.55K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.26M | 422.2K | -125.67K | 125.67K | 87.15K | 135.74K | -554.61K | 630.62K | -167.93K | -573.37K | -6.89K | 451.01K | 222.13K | 494.55K | -431.87K | -275.77K | 69.05K | 75.38K | -442.8K | 152.75K |
Operating Cash Flow | -1.04M | -509.89K | -1.05M | -373.3K | -332.96K | -177.1K | -1.98M | 342.96K | -288.39K | -541.7K | -1.88M | -1.08M | -1.19M | -298.64K | -1.39M | -1.24M | -940.3K | -589.13K | -1.25M | -551K |
Capital Expenditures | n/a | 3.00 | -5 | -3 | n/a | 4.00 | 4.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | 7M | -7M | 5M | -5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -5,000B | n/a | -643.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 7M | -7M | -5,000B | -5M | -643.25K | n/a | n/a | n/a | n/a | n/a | n/a | -55.69M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50.8K | n/a | n/a | n/a | n/a | -38.17K | -37.74K | -37.34K |
Common Stock Repurchased | -171.54K | -3.95M | -10.74M | -10.17M | -10.7M | -7.04M | -164.95K | -26.46M | -4.31M | -3.78M | -3.39M | -2.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | -16.19M | n/a | -22,457.2B | n/a | n/a | -319.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 16.19M | n/a | 22,457.2B | n/a | n/a | -1.94M | n/a | n/a | n/a | 880.00 | -31.67M | n/a | 31.67M | n/a | 50.8K | -0.00 | n/a | n/a |
Financial Cash Flow | -171.54K | -3.95M | -10.74M | -10.17M | -10.7M | -7.04M | 748.69K | 6.28M | -4.31M | -3.78M | -3.39M | -2.09M | -50.8K | 55.69M | 87.36M | n/a | 50.8K | -38.17K | 2.8M | 1.82M |
Net Cash Flow | -1.21M | -4.46M | -11.8M | -17.54M | -11.03M | -12.21M | -1.24M | 6.62M | -4.6M | -4.32M | -5.27M | -3.17M | -1.24M | -298.86K | 85.98M | -1.24M | -888.87K | -626.43K | 1.55M | 1.27M |
Free Cash Flow | -1.04M | -509.89K | -1.05M | -373.3K | -332.96K | -177.1K | -1.98M | 342.96K | -288.39K | -541.7K | -1.88M | -1.08M | -1.19M | -298.64K | -1.39M | -1.24M | -940.3K | -589.13K | -1.25M | -551K |